Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Clinical trial NCT03199963 · TERMINATED

Trial details

NCT number: NCT03199963
Sponsor: BHR Pharma, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Mammographic Breast Density

Start date: 2017-08-21
Primary completion: 2019-01-14
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.